Consolidated Statements of Stockholders' Equity - USD ($) shares in Thousands, $ in Thousands |
Total |
Additional Paid-in Capital |
Additional Paid-in Capital
Cumulative Effect, Period of Adoption, Adjustment
|
Accumulated Deficit |
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
|
Accumulated Other Comprehensive Income (Loss) |
Class A Common Stock |
Class A Common Stock
Common Stock
|
Class B Voting Common Stock |
Class B Voting Common Stock
Common Stock
|
Class C Voting Common Stock |
Class C Voting Common Stock
Common Stock
|
| Balance, beginning of period, shares at Dec. 31, 2020 |
|
|
|
|
|
|
|
1,248,010
|
|
23,696
|
|
231,627
|
| Balance, beginning of period at Dec. 31, 2020 |
|
$ 10,200,141
|
$ (664,021)
|
$ (7,891,542)
|
$ 95,031
|
$ 21,363
|
|
$ 12
|
|
|
|
$ 2
|
| Stock-based compensation expense |
|
493,004
|
|
|
|
|
|
|
|
|
|
|
| Shares issued in connection with exercise of stock options under stock-based compensation plans, shares |
|
|
|
|
|
|
|
548
|
|
8
|
|
|
| Shares issued in connection with exercise of stock options under stock-based compensation plans |
|
7,710
|
|
|
|
|
|
|
|
|
|
|
| Issuance of non-voting common stock in connection with acquisitions , shares |
|
|
|
|
|
|
|
5,733
|
|
|
|
|
| Issuance of Class A non-voting common stock in connection with acquisitions |
|
308,636
|
|
|
|
|
|
|
|
|
|
|
| Issuance of voting/non-voting common stock for vesting of restricted stock units and restricted stock awards, net, shares |
|
|
|
|
|
|
|
28,724
|
|
|
|
|
| Issuance of non-voting common stock for vesting of restricted stock units and restricted stock awards, net |
|
|
|
|
|
|
|
$ 1
|
|
|
|
|
| Issuance of Class A non-voting common stock for the induced conversion related to convertible senior notes |
|
870,551
|
|
|
|
|
|
|
|
|
|
|
| Issuance of Class A non-voting common stock for the induced conversion related to convertible senior notes, shares |
|
|
|
|
|
|
|
38,398
|
|
|
|
|
| Conversion of stock to voting/non-voting common stock, shares |
|
|
|
|
|
|
|
64
|
|
(64)
|
|
|
| Purchase of capped calls |
|
(86,825)
|
|
|
|
|
|
|
|
|
|
|
| Net loss |
$ (438,546)
|
|
|
(438,546)
|
|
|
$ (365,112)
|
|
$ (6,805)
|
|
$ (66,629)
|
|
| Other comprehensive income (loss), net of tax |
$ (7,516)
|
|
|
|
|
(7,516)
|
|
|
|
|
|
|
| Balance, end of period, shares at Jun. 30, 2021 |
1,576,744
|
|
|
|
|
|
|
1,321,477
|
|
23,640
|
|
231,627
|
| Balance, end of period at Jun. 30, 2021 |
$ 2,908,001
|
11,129,196
|
|
(8,235,057)
|
|
13,847
|
|
$ 13
|
|
|
|
$ 2
|
| Balance, beginning of period, shares at Dec. 31, 2020 |
|
|
|
|
|
|
|
1,248,010
|
|
23,696
|
|
231,627
|
| Balance, beginning of period at Dec. 31, 2020 |
|
10,200,141
|
$ (664,021)
|
(7,891,542)
|
$ 95,031
|
21,363
|
|
$ 12
|
|
|
|
$ 2
|
| Balance, end of period, shares at Dec. 31, 2021 |
|
|
|
|
|
|
|
1,364,887
|
|
22,769
|
|
231,627
|
| Balance, end of period at Dec. 31, 2021 |
3,790,168
|
12,069,097
|
|
(8,284,466)
|
|
5,521
|
|
$ 14
|
|
|
|
$ 2
|
| Balance, beginning of period, shares at Mar. 31, 2021 |
|
|
|
|
|
|
|
1,263,733
|
|
23,640
|
|
231,627
|
| Balance, beginning of period at Mar. 31, 2021 |
|
9,777,646
|
|
(8,083,393)
|
|
11,910
|
|
$ 13
|
|
|
|
$ 2
|
| Stock-based compensation expense |
|
255,931
|
|
|
|
|
|
|
|
|
|
|
| Shares issued in connection with exercise of stock options under stock-based compensation plans, shares |
|
|
|
|
|
|
|
235
|
|
3
|
|
|
| Shares issued in connection with exercise of stock options under stock-based compensation plans |
|
3,257
|
|
|
|
|
|
|
|
|
|
|
| Issuance of non-voting common stock in connection with acquisitions , shares |
|
|
|
|
|
|
|
5,733
|
|
|
|
|
| Issuance of Class A non-voting common stock in connection with acquisitions |
|
308,636
|
|
|
|
|
|
|
|
|
|
|
| Issuance of voting/non-voting common stock for vesting of restricted stock units and restricted stock awards, net, shares |
|
|
|
|
|
|
|
13,375
|
|
|
|
|
| Issuance of Class A non-voting common stock for the induced conversion related to convertible senior notes |
|
870,551
|
|
|
|
|
|
|
|
|
|
|
| Issuance of Class A non-voting common stock for the induced conversion related to convertible senior notes, shares |
|
|
|
|
|
|
|
38,398
|
|
|
|
|
| Conversion of stock to voting/non-voting common stock, shares |
|
|
|
|
|
|
|
3
|
|
(3)
|
|
|
| Purchase of capped calls |
|
(86,825)
|
|
|
|
|
|
|
|
|
|
|
| Net loss |
(151,664)
|
|
|
(151,664)
|
|
|
(126,642)
|
|
(2,317)
|
|
(22,705)
|
|
| Other comprehensive income (loss), net of tax |
$ 1,937
|
|
|
|
|
1,937
|
|
|
|
|
|
|
| Balance, end of period, shares at Jun. 30, 2021 |
1,576,744
|
|
|
|
|
|
|
1,321,477
|
|
23,640
|
|
231,627
|
| Balance, end of period at Jun. 30, 2021 |
$ 2,908,001
|
11,129,196
|
|
(8,235,057)
|
|
13,847
|
|
$ 13
|
|
|
|
$ 2
|
| Balance, beginning of period, shares at Dec. 31, 2021 |
|
|
|
|
|
|
|
1,364,887
|
|
22,769
|
|
231,627
|
| Balance, beginning of period at Dec. 31, 2021 |
3,790,168
|
12,069,097
|
|
(8,284,466)
|
|
5,521
|
|
$ 14
|
|
|
|
$ 2
|
| Stock-based compensation expense |
|
589,944
|
|
|
|
|
|
|
|
|
|
|
| Shares issued in connection with exercise of stock options under stock-based compensation plans, shares |
|
|
|
|
|
|
|
260
|
|
10
|
|
|
| Shares issued in connection with exercise of stock options under stock-based compensation plans |
|
3,663
|
|
|
|
|
|
|
|
|
|
|
| Issuance of non-voting common stock in connection with acquisitions , shares |
|
|
|
|
|
|
|
1,277
|
|
|
|
|
| Issuance of Class A non-voting common stock in connection with acquisitions |
|
44,039
|
|
|
|
|
|
|
|
|
|
|
| Issuance of voting/non-voting common stock for vesting of restricted stock units and restricted stock awards, net, shares |
|
|
|
|
|
|
|
24,144
|
|
|
|
|
| Conversion of stock to voting/non-voting common stock, shares |
|
|
|
|
|
|
|
141
|
|
(141)
|
|
|
| Purchase of capped calls |
|
(177,000)
|
|
|
|
|
|
|
|
|
|
|
| Net loss |
(781,691)
|
|
|
(781,691)
|
|
|
(659,409)
|
|
(10,905)
|
|
(111,377)
|
|
| Other comprehensive income (loss), net of tax |
$ (25,364)
|
|
|
|
|
(25,364)
|
|
|
|
|
|
|
| Balance, end of period, shares at Jun. 30, 2022 |
1,644,974
|
|
|
|
|
|
|
1,390,709
|
|
22,638
|
|
231,627
|
| Balance, end of period at Jun. 30, 2022 |
$ 3,443,759
|
12,529,743
|
|
(9,066,157)
|
|
(19,843)
|
|
$ 14
|
|
|
|
$ 2
|
| Balance, beginning of period, shares at Mar. 31, 2022 |
|
|
|
|
|
|
|
1,378,259
|
|
22,677
|
|
231,627
|
| Balance, beginning of period at Mar. 31, 2022 |
|
12,211,123
|
|
(8,644,090)
|
|
(4,013)
|
|
$ 14
|
|
|
|
$ 2
|
| Stock-based compensation expense |
|
317,224
|
|
|
|
|
|
|
|
|
|
|
| Shares issued in connection with exercise of stock options under stock-based compensation plans, shares |
|
|
|
|
|
|
|
100
|
|
4
|
|
|
| Shares issued in connection with exercise of stock options under stock-based compensation plans |
|
1,396
|
|
|
|
|
|
|
|
|
|
|
| Issuance of non-voting common stock in connection with acquisitions , shares |
|
|
|
|
|
|
|
159
|
|
|
|
|
| Issuance of voting/non-voting common stock for vesting of restricted stock units and restricted stock awards, net, shares |
|
|
|
|
|
|
|
12,148
|
|
|
|
|
| Conversion of stock to voting/non-voting common stock, shares |
|
|
|
|
|
|
|
43
|
|
(43)
|
|
|
| Net loss |
(422,067)
|
|
|
(422,067)
|
|
|
$ (356,314)
|
|
$ (5,855)
|
|
$ (59,898)
|
|
| Other comprehensive income (loss), net of tax |
$ (15,830)
|
|
|
|
|
(15,830)
|
|
|
|
|
|
|
| Balance, end of period, shares at Jun. 30, 2022 |
1,644,974
|
|
|
|
|
|
|
1,390,709
|
|
22,638
|
|
231,627
|
| Balance, end of period at Jun. 30, 2022 |
$ 3,443,759
|
$ 12,529,743
|
|
$ (9,066,157)
|
|
$ (19,843)
|
|
$ 14
|
|
|
|
$ 2
|